Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;37(4):273-7.
doi: 10.3760/cma.j.issn.0253-2727.2016.04.003.

[Expression of microRNA-191 in T lymphoblastic leukemia/lymphoma and its underlying mechanism]

[Article in Chinese]
Jinghang Zhang  1 , Xaioyu Yang, Min Li, Xin Huang, Cuiling Liu, Zifen Gao
Affiliations

[Expression of microRNA-191 in T lymphoblastic leukemia/lymphoma and its underlying mechanism]

[Article in Chinese]
Jinghang Zhang et al. Zhonghua Xue Ye Xue Za Zhi. 2016 Apr.

Abstract
in English, Chinese

Objective: To evaluate the correlation between MicroRNA-191 (miR-191) and T lymphoblastic leukemia/lymphoma (T-ALL/LBL) to probe its underlying molecular mechanism.

Methods: The expression of miR-191 was examined by real-time PCR (RT-PCR) in 20 T-ALL/LBL tissue samples and 20 lymphoid reactive hyperplasia (LRH) tissue samples. The correlation between miR-191 and the clinicopathological feature of T-ALL/LBL was analyzed. Antisense miR-191 lentiviral vectors was constructed and transfected into T-ALL/LBL Jukat cells. After transfection, the expression of miR-191 was examined by RT-PCR. The cell activity was evaluated by CCK-8 asssy. The cell cycle and apoptosis were determined by flow cytometry.

Results: Compared with LRH samples, the results of RT-PCR showed significant upregulation of miR-191 in 20 T-ALL/LBL tissue samples (1.875±0.079 vs 1.000, P<0.05). The expression level of miR-191 was negatively associated with prognosis. Compared with LV-NC-GFP and control groups, the expression of miR-191 significantly decreased after transfection of antisense miR-191 lentiviral vectors (0.578±0.012 vs 1.011±0.053 and 1.000, P<0.05), the percentages of apoptotic cells and the cell in G0/G1 phase significantly increased (P<0.05).

Conclusions: miR-191 might play a significant role in the development of T-ALL/LBL, implicating a new target for therapy.

目的: 探讨MicroRNA-191（miR-191）与T淋巴母细胞性白血病/淋巴瘤（T-ALL/LBL）的相关性及其作用机制。

方法: 采用荧光实时定量PCR（qRT-PCR）法检测20例T-ALL/LBL患者肿瘤组织和20例淋巴结反应性增生（LRH）患者淋巴结组织中miR-191的表达，并分析其与临床预后的关系。构建反义miR-191慢病毒载体（LV-miR-191-KD）和阴性对照载体（LV-NC-GFP）并转染T-ALL细胞系Jurkat细胞，qRT-PCR法检测miR-191的表达水平。分别用CCK-8法和流式细胞术检测下调miR-191后的细胞活性、细胞周期和凋亡。

结果: T-ALL/LBL患者组miR-191表达水平明显高于LRH患者组（1.875±0.079对1.000，P=0.001），以miR-191表达量的中位数为界，将T-ALL/LBL患者分为高表达组（10例）与低表达组（10例），高表达组患者3年OS率明显低于低表达组（26%对82%，P=0.021）。转染48 h后，LV-miR-191-KD组Jurkat细胞miR-191表达水平（0.578±0.012）较LV-NC-GFP组（1.011±0.053）和未转染对照组（1.000）显著降低（P值分别为0.018和0.021），细胞凋亡比例显著升高（P值均<0.05），细胞周期阻滞于G0/G1期，并抑制从G1期向S期转化。

结论: miR-191在T-ALL/LBL的发生、发展过程中起促进作用，可能作为T-ALL/LBL治疗的潜在靶点。

PubMed Disclaimer

Figures

图1
图1. MicroRNA（miR）-191表达对T淋巴母细胞性白血病/淋巴瘤患者总生存的影响
图2
图2. 流式细胞术检测MicroRNA（miR）-191表达对Jurkat细胞凋亡的影响
A：未转染对照组；B：LV-NC-GFP转染组；C：LV-miR-191-KD转染组
图3
图3. CCK-8法检测MicroRNA（miR）-191表达对Jurkat细胞增殖的影响（每组设3个复孔，实验重复3次）
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia[J] N Engl J Med. 2006;354(2):166–178. - PubMed
    1. Wynendaele J, Böhnke A, Leucci E, et al. An illegitimate microRNA target site within the 3′ UTR of MDM4 affects ovarian cancer progression and chemosensitivity[J] Cancer Res. 2010;70(23):9641–9649. doi: 10.1158/0008-5472.CAN-10-0527. - DOI - PubMed
    1. Elyakim E, Sitbon E, Faerman A, et al. hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy[J] Cancer Res. 2010;70(20):8077–8087. doi: 10.1158/0008-5472.CAN-10-1313. - DOI - PubMed
    1. Zhang L, Flygare J, Wong P, et al. miR-191 regulates mouse erythroblast enucleation by down-regulating Riok3 and Mxi1[J] Genes Dev. 2011;25(2):119–124. doi: 10.1101/gad.1998711. - DOI - PMC - PubMed
    1. Shen J, DiCioccio R, Odunsi K, et al. Novel genetic variants in miR-191 gene and familial ovarian cancer[J] BMC Cancer. 2010;10:47. doi: 10.1186/1471-2407-10-47. - DOI - PMC - PubMed